NLRP3 and cardiomyopathy: In mice with LPS-induced cardiomyopathy, sodium tanshinone IIA sulfonate mitigates myocardial inflammation and enhances cardiac function by promoting autophagy and inhibiting NLRP3 inflammasome activation, leading to increased survival rates (181).